KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Return on Equity (2020 - 2025)

Organon (OGN) has 6 years of Return on Equity data on record, last reported at 0.23% in Q4 2025.

  • For Q4 2025, Return on Equity fell 157.0% year-over-year to 0.23%; the TTM value through Dec 2025 reached 0.23%, down 157.0%, while the annual FY2025 figure was 0.31%, 399.0% down from the prior year.
  • Return on Equity reached 0.23% in Q4 2025 per OGN's latest filing, down from 0.61% in the prior quarter.
  • Across five years, Return on Equity topped out at 10.42% in Q2 2024 and bottomed at 95.18% in Q1 2024.
  • Average Return on Equity over 5 years is 5.02%, with a median of 0.0% recorded in 2022.
  • Peak YoY movement for Return on Equity: tumbled -9496bps in 2024, then skyrocketed 9666bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then crashed by -36bps to 0.0% in 2022, then tumbled by -107135bps to 3.1% in 2023, then soared by 158bps to 1.79% in 2024, then plummeted by -87bps to 0.23% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.23% in Q4 2025, 0.61% in Q3 2025, and 1.1% in Q2 2025.